Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON45271Recruiting
Open-label, single-arm trial in sepsis and Infectious disease, sponsored by Amsterdam UMC, location VUmc. Primary endpoints: Agreement between predicted and observed relevant pharmacometric parameters, Percentage of correct first predictions of each pharmacometric model and 1 more. Started Jul 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON45271.